Beijing Hotgen Biotech Co Ltd (688068) — Free Cash Flow Generation Index
Beijing Hotgen Biotech Co Ltd (688068) has a Free Cash Flow Generation Index of -3.82x as of September 2025. Free cash flow of CN¥-11.68 Million represents -4% of operating cash flow (CN¥3.05 Million). See 688068 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Beijing Hotgen Biotech Co Ltd Free Cash Flow Generation Index (2016–2022)
Historical FCF Generation Index trend for Beijing Hotgen Biotech Co Ltd across 7 annual periods. Explore how well can Beijing Hotgen Biotech Co Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Beijing Hotgen Biotech Co Ltd (2016–2022)
Year-by-year Free Cash Flow Generation Index for Beijing Hotgen Biotech Co Ltd. For the full company profile including market capitalisation, see 688068 stock market capitalisation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.42x | CN¥413.54 Million | CN¥978.75 Million | CN¥565.21 Million | ▼ -50.2% |
| 2021 | 0.85x | CN¥2.25 Billion | CN¥2.64 Billion | CN¥398.86 Million | ▲ +1928.4% |
| 2020 | -0.05x | CN¥-7.65 Million | CN¥164.62 Million | CN¥172.27 Million | ▲ +98.7% |
| 2019 | -3.57x | CN¥-69.11 Million | CN¥19.37 Million | CN¥88.48 Million | ▼ -1606.4% |
| 2018 | 0.24x | CN¥13.03 Million | CN¥55.04 Million | CN¥42.00 Million | ▲ +111.8% |
| 2017 | -2.01x | CN¥-46.10 Million | CN¥22.95 Million | CN¥69.05 Million | ▼ -475.5% |
| 2016 | 0.53x | CN¥24.36 Million | CN¥45.54 Million | CN¥21.18 Million | — |